Comparative Effectiveness of Cystine Versus Nicotine Replacement Therapy
Comparative Effectiveness of Cystine Versus Nicotine Replacement Therapy (NRT) in the National Smoking Cessation Program of Mongolia: A Pragmatic Non-Inferiority Trial
Sponsor: Loma Linda University
A PHASE4 clinical study on Nicotine Addiction, this trial is completed. The trial is conducted by Loma Linda University and has accumulated 13 data snapshots since 2022. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
13 versions recorded-
Oct 2024 — Present [monthly]
Completed PHASE4
Status: Recruiting → Completed · Phase: PHASE3 → PHASE4
-
Sep 2024 — Oct 2024 [monthly]
Recruiting PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Recruiting PHASE3
-
Dec 2023 — Jul 2024 [monthly]
Recruiting PHASE3
-
Sep 2023 — Dec 2023 [monthly]
Recruiting PHASE3
▶ Show 8 earlier versions
-
May 2023 — Sep 2023 [monthly]
Recruiting PHASE3
-
Mar 2023 — May 2023 [monthly]
Recruiting PHASE3
-
Mar 2022 — Mar 2023 [monthly]
Recruiting PHASE3
Status: Not Yet Recruiting → Recruiting
-
Oct 2021 — Mar 2022 [monthly]
Not Yet Recruiting PHASE3
-
Sep 2021 — Oct 2021 [monthly]
Not Yet Recruiting PHASE3
-
May 2021 — Sep 2021 [monthly]
Not Yet Recruiting PHASE3
-
Jan 2021 — May 2021 [monthly]
Not Yet Recruiting PHASE3
-
Nov 2019 — Jan 2021 [monthly]
Not Yet Recruiting PHASE3
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Loma Linda University
- Mongolian National University of Medical Sciences
- Pfizer
For direct contact, visit the study record on ClinicalTrials.gov .